Search

Physiological mechanisms of hyperacusis: an update

Hyperacusis is a heterogeneous and complex clinical entity, and proposals about physiological mechanisms should reflect these issues. Ben Auerbach helps us navigate through present knowledge in this area, and proposes future directions for research. Hyperacusis is a debilitating hearing disorder...

New hearing healthcare service-delivery models with connected technologies

Connected hearing healthcare can improve access to affordable hearing healthcare. DeWet Swanepoel discuss how innovative trends in connectivity and technology offer opportunities for novel and decentralised models of delivering high-quality hearing healthcare. Megatrends in connectivity and technology have ushered in...

The British Laryngological Association and Industry

In 2011 British laryngologists Martin Birchall and Guri Sandhu, assisted by ENT SpR Chad Al Yagachi, organised the first highly successful three-day international ‘Cutting-Edge Laryngology for the 21st Century’ conference at the Royal College of Surgeons in London. The Kenes...

Developing medical devices for children: opportunities and challenges

The development of medical devices for infants and children lags significantly behind the development of devices for adults. While in the United States the Food and Drug Administration (FDA) has set up incentives for developing child age-specific pharmaceuticals, there is...

The outer ear in the visual arts

The ear is an exceptional organ, and quite rightly takes its place in the visual arts, as described by Albert Mudry, who takes us on a whistle-stop tour of the appearance of the ear and its depictions in art throughout...

Funding your otolaryngology / audiology idea by partnering with 
the US Department of Defense

The United States Department of Defense (DoD) has been an effective partner in many of our current medical technology advancements, from the surgical robot, to improved clotting wound dressings, to better blood products. For the otolaryngology and audiology entrepreneur looking...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Specialist teams deliver world-class trauma care

University Hospitals Birmingham NHS Foundation Trust runs the Queen Elizabeth Hospital Birmingham, which is a designated Major Trauma Centre. The Trust holds the contract to treat all UK injured military personnel evacuated from combat zones overseas. More than 1200 of...

In conversation with John Carlisle: the silent hero shaping medical publication integrity

Have you ever been curious as to what your anaesthetist is getting up to on their laptop during long cases? Me neither, but I always generally assumed they were trading Bitcoin, solving the Riemann hypothesis and buffing their Tinder profile....

Developments in diagnostic approaches for acutely dizzy patients

The acutely dizzy patient can be a diagnostic and management dilemma for emergency departments and general practitioners, with many patients consequently having delayed access to specialised assessment and treatment. David Jay tells us about HINTS, a bedside test that can...